Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions
OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we sh...
Gespeichert in:
Veröffentlicht in: | American journal of obstetrics and gynecology 1995-04, Vol.172 (4), p.1216-1223 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1223 |
---|---|
container_issue | 4 |
container_start_page | 1216 |
container_title | American journal of obstetrics and gynecology |
container_volume | 172 |
creator | Collins, Patricia L. Idriss, Edo Moore, John J. |
description | OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions.
STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E
2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance.
RESULTS: Fetal membranes reversibly inhibited prostaglandin E
2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions.
CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective. |
doi_str_mv | 10.1016/0002-9378(95)91482-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77236458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000293789591482X</els_id><sourcerecordid>77236458</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</originalsourceid><addsrcrecordid>eNp9kE1rFEEQhhtRkk3MPzAwB5HkMNrfHxdBQhKFgAcN5Nb0dNdoy0xP7O4R8-_tzS579FQU9VTx1oPQG4LfE0zkB4wx7Q1T-sKIS0O4pv3DC7Qh2Kheaqlfos0BOUYnpfzattTQI3SkFJVUmA36dgPVTd0M85BdgtLF9DMOsXaPeSnV_ZhcCjF1w1q7tNRu-ftUFx9TH1NYPYRurZBjgs4vqWbna1xSeY1ejW4qcLavp-j-5vr71ef-7uvtl6tPd71nWtaeSy0GQdiovVHYjIMCyYdgRq2l5BgLPWjDeDDKGKko0zwEIzxnQVEsHGan6N3ubsv6e4VS7RyLh6llhmUttj3JJBe6gXwH-vZUyTDaxxxnl58swXbr0m7N2K0oa4R9dmkf2tr5_v46zBAOS3t5bf52P3fFu2lsAn0sB4wJignhDfu4w6C5-BMh2-IjpGYvZvDVhiX-P8c_7FKQHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77236458</pqid></control><display><type>article</type><title>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Collins, Patricia L. ; Idriss, Edo ; Moore, John J.</creator><creatorcontrib>Collins, Patricia L. ; Idriss, Edo ; Moore, John J.</creatorcontrib><description>OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions.
STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E
2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance.
RESULTS: Fetal membranes reversibly inhibited prostaglandin E
2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions.
CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/0002-9378(95)91482-X</identifier><identifier>PMID: 7726259</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Mosby, Inc</publisher><subject>Analysis of Variance ; Animals ; Biological and medical sciences ; Dinoprostone - pharmacology ; Extraembryonic Membranes - enzymology ; Extraembryonic Membranes - physiology ; Female ; Fetal membranes ; Genital system. Reproduction ; Humans ; In Vitro Techniques ; L-Lactate Dehydrogenase - metabolism ; Medical sciences ; Muscle, Smooth - drug effects ; Muscle, Smooth - enzymology ; Muscle, Smooth - physiology ; oxytocin ; Oxytocin - pharmacology ; paracrine signaling ; Pharmacology. Drug treatments ; Pregnancy ; prostaglandins ; Rats ; Rats, Wistar ; Uterine Contraction - drug effects ; Uterus - drug effects ; Uterus - enzymology ; Uterus - physiology</subject><ispartof>American journal of obstetrics and gynecology, 1995-04, Vol.172 (4), p.1216-1223</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</citedby><cites>FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-9378(95)91482-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3549,23929,23930,25139,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3520114$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7726259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Collins, Patricia L.</creatorcontrib><creatorcontrib>Idriss, Edo</creatorcontrib><creatorcontrib>Moore, John J.</creatorcontrib><title>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions.
STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E
2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance.
RESULTS: Fetal membranes reversibly inhibited prostaglandin E
2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions.
CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Dinoprostone - pharmacology</subject><subject>Extraembryonic Membranes - enzymology</subject><subject>Extraembryonic Membranes - physiology</subject><subject>Female</subject><subject>Fetal membranes</subject><subject>Genital system. Reproduction</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Medical sciences</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - enzymology</subject><subject>Muscle, Smooth - physiology</subject><subject>oxytocin</subject><subject>Oxytocin - pharmacology</subject><subject>paracrine signaling</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>prostaglandins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Uterine Contraction - drug effects</subject><subject>Uterus - drug effects</subject><subject>Uterus - enzymology</subject><subject>Uterus - physiology</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rFEEQhhtRkk3MPzAwB5HkMNrfHxdBQhKFgAcN5Nb0dNdoy0xP7O4R8-_tzS579FQU9VTx1oPQG4LfE0zkB4wx7Q1T-sKIS0O4pv3DC7Qh2Kheaqlfos0BOUYnpfzattTQI3SkFJVUmA36dgPVTd0M85BdgtLF9DMOsXaPeSnV_ZhcCjF1w1q7tNRu-ftUFx9TH1NYPYRurZBjgs4vqWbna1xSeY1ejW4qcLavp-j-5vr71ef-7uvtl6tPd71nWtaeSy0GQdiovVHYjIMCyYdgRq2l5BgLPWjDeDDKGKko0zwEIzxnQVEsHGan6N3ubsv6e4VS7RyLh6llhmUttj3JJBe6gXwH-vZUyTDaxxxnl58swXbr0m7N2K0oa4R9dmkf2tr5_v46zBAOS3t5bf52P3fFu2lsAn0sB4wJignhDfu4w6C5-BMh2-IjpGYvZvDVhiX-P8c_7FKQHw</recordid><startdate>19950401</startdate><enddate>19950401</enddate><creator>Collins, Patricia L.</creator><creator>Idriss, Edo</creator><creator>Moore, John J.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950401</creationdate><title>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</title><author>Collins, Patricia L. ; Idriss, Edo ; Moore, John J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-4685b513f8c9709fb7e64bd9f886640058b8934d9799672384dd95c43d7205a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Dinoprostone - pharmacology</topic><topic>Extraembryonic Membranes - enzymology</topic><topic>Extraembryonic Membranes - physiology</topic><topic>Female</topic><topic>Fetal membranes</topic><topic>Genital system. Reproduction</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Medical sciences</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - enzymology</topic><topic>Muscle, Smooth - physiology</topic><topic>oxytocin</topic><topic>Oxytocin - pharmacology</topic><topic>paracrine signaling</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>prostaglandins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Uterine Contraction - drug effects</topic><topic>Uterus - drug effects</topic><topic>Uterus - enzymology</topic><topic>Uterus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collins, Patricia L.</creatorcontrib><creatorcontrib>Idriss, Edo</creatorcontrib><creatorcontrib>Moore, John J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collins, Patricia L.</au><au>Idriss, Edo</au><au>Moore, John J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>1995-04-01</date><risdate>1995</risdate><volume>172</volume><issue>4</issue><spage>1216</spage><epage>1223</epage><pages>1216-1223</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>OBJECTIVE: Paracrine signaling in fetal membranes and uterus is hypothesized to play a role in the initiation of labor in women. Numerous fetal membrane signals that stimulate uterine contractions have been described. Recently, by means of the dual-chamber, fetal membrane, uteirne muscle model we showed that fetal membranes inhibit spontaneous uterine contractions. This study was designed to test whether human fetal membranes can also inhibit agonist-induced uterine contractions.
STUDY DESIGN: A rat uterine muscle strip was mounte dinto the maternal side of a Plexiglas acrylic plastic chamber, Uterino contractions were recorded for 3 hours after the addition of either 50 nmol/L prostaglandin E
2 or 0.1 nmol/L oxytocin to the maternal side of the chamber. During the first and third hours no fetal membranes were present (basal condition). At the beginning of the second hour fetal membranes were inserted into the chamber so that they divided the chamber into maternal and fetal compartments. The membranes were removed before the beginning of the third hour. The integrated force of uterine contractions during the second hour, when the muscle was exposed to fetal membranes, was compared with the basal condition (first and third hours) by repeated-measure analysis of variance.
RESULTS: Fetal membranes reversibly inhibited prostaglandin E
2-induced uterine contractions by 22%. Fetal membranes did not inhibit oxytocin-induced uterine contractions.
CONCLUSIONS: Fetal membranes inhibit agonist-induced uterine contractions. The fetal membrane inhibitory system is agonist selective.</abstract><cop>Philadelphia, PA</cop><pub>Mosby, Inc</pub><pmid>7726259</pmid><doi>10.1016/0002-9378(95)91482-X</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9378 |
ispartof | American journal of obstetrics and gynecology, 1995-04, Vol.172 (4), p.1216-1223 |
issn | 0002-9378 1097-6868 |
language | eng |
recordid | cdi_proquest_miscellaneous_77236458 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Analysis of Variance Animals Biological and medical sciences Dinoprostone - pharmacology Extraembryonic Membranes - enzymology Extraembryonic Membranes - physiology Female Fetal membranes Genital system. Reproduction Humans In Vitro Techniques L-Lactate Dehydrogenase - metabolism Medical sciences Muscle, Smooth - drug effects Muscle, Smooth - enzymology Muscle, Smooth - physiology oxytocin Oxytocin - pharmacology paracrine signaling Pharmacology. Drug treatments Pregnancy prostaglandins Rats Rats, Wistar Uterine Contraction - drug effects Uterus - drug effects Uterus - enzymology Uterus - physiology |
title | Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T03%3A18%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20membranes%20inhibit%20prostaglandin%20but%20not%20oxytocin-induced%20uterine%20contractions&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Collins,%20Patricia%20L.&rft.date=1995-04-01&rft.volume=172&rft.issue=4&rft.spage=1216&rft.epage=1223&rft.pages=1216-1223&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1016/0002-9378(95)91482-X&rft_dat=%3Cproquest_cross%3E77236458%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77236458&rft_id=info:pmid/7726259&rft_els_id=000293789591482X&rfr_iscdi=true |